Cencora EBITDA Margin 2010-2025 | COR
Cencora EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2025-03-31 | $310.23B | $3.65B | 1.18% |
2024-12-31 | $303.19B | $3.18B | 1.05% |
2024-09-30 | $293.96B | $3.29B | 1.12% |
2024-06-30 | $283.83B | $3.65B | 1.29% |
2024-03-31 | $276.54B | $3.64B | 1.32% |
2023-12-31 | $271.58B | $3.61B | 1.33% |
2023-09-30 | $262.17B | $3.32B | 1.27% |
2023-06-30 | $254.43B | $3.19B | 1.25% |
2023-03-31 | $247.54B | $2.91B | 1.17% |
2022-12-31 | $241.81B | $3.06B | 1.27% |
2022-09-30 | $238.59B | $3.08B | 1.29% |
2022-06-30 | $236.33B | $3.22B | 1.36% |
2022-03-31 | $229.67B | $3.31B | 1.44% |
2021-12-31 | $221.10B | $3.07B | 1.39% |
2021-09-30 | $213.99B | $2.90B | 1.36% |
2021-06-30 | $204.32B | $-3.52B | -1.72% |
2021-03-31 | $196.28B | $-3.77B | -1.92% |
2020-12-31 | $194.55B | $-4.09B | -2.10% |
2020-09-30 | $189.90B | $-4.37B | -2.30% |
2020-06-30 | $186.29B | $1.58B | 0.85% |
2020-03-31 | $186.16B | $1.60B | 0.86% |
2019-12-31 | $182.06B | $1.37B | 0.75% |
2019-09-30 | $179.59B | $1.61B | 0.90% |
2019-06-30 | $177.25B | $1.66B | 0.93% |
2019-03-31 | $175.15B | $1.67B | 0.96% |
2018-12-31 | $172.87B | $2.10B | 1.21% |
2018-09-30 | $167.94B | $2.01B | 1.20% |
2018-06-30 | $163.76B | $1.65B | 1.01% |
2018-03-31 | $159.33B | $1.39B | 0.87% |
2017-12-31 | $155.44B | $1.52B | 0.98% |
2017-09-30 | $153.14B | $1.49B | 0.97% |
2017-06-30 | $151.58B | $1.84B | 1.22% |
2017-03-31 | $149.76B | $2.19B | 1.47% |
2016-12-31 | $148.31B | $2.51B | 1.69% |
2016-09-30 | $146.85B | $1.92B | 1.31% |
2016-06-30 | $144.76B | $2.21B | 1.53% |
2016-03-31 | $142.11B | $1.98B | 1.40% |
2015-12-31 | $139.08B | $0.63B | 0.45% |
2015-09-30 | $135.96B | $0.68B | 0.50% |
2015-06-30 | $132.08B | $0.32B | 0.25% |
2015-03-31 | $128.20B | $0.08B | 0.06% |
2014-12-31 | $123.98B | $0.74B | 0.59% |
2014-09-30 | $119.57B | $0.98B | 0.82% |
2014-06-30 | $112.45B | $0.87B | 0.77% |
2014-03-31 | $104.01B | $0.89B | 0.85% |
2013-12-31 | $96.08B | $0.93B | 0.97% |
2013-09-30 | $87.96B | $1.07B | 1.22% |
2013-06-30 | $82.23B | $1.27B | 1.55% |
2013-03-31 | $79.65B | $1.46B | 1.83% |
2012-12-31 | $78.83B | $1.47B | 1.87% |
2012-09-30 | $78.08B | $1.44B | 1.85% |
2012-06-30 | $78.23B | $1.33B | 1.70% |
2012-03-31 | $79.07B | $1.32B | 1.66% |
2011-12-31 | $79.12B | $1.30B | 1.65% |
2011-09-30 | $78.70B | $1.30B | 1.65% |
2011-06-30 | $79.35B | $1.30B | 1.64% |
2011-03-31 | $78.79B | $1.26B | 1.60% |
2010-12-31 | $78.33B | $1.20B | 1.53% |
2010-09-30 | $77.78B | $1.18B | 1.52% |
2010-06-30 | $76.96B | $1.18B | 1.54% |
2010-03-31 | $75.75B | $1.11B | 1.47% |
2009-12-31 | $73.76B | $1.05B | 1.42% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $56.866B | $293.959B |
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $135.390B | 25.39 |
Elevance Health (ELV) | United States | $84.947B | 10.96 |
CVS Health (CVS) | United States | $77.596B | 9.64 |
DiDi Global (DIDIY) | China | $22.921B | 34.79 |
Natera (NTRA) | United States | $21.460B | 0.00 |
BioMerieux (BMXMF) | France | $15.355B | 0.00 |
Solventum (SOLV) | United States | $12.549B | 13.28 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.465B | 0.00 |
CochLear (CHEOY) | Australia | $11.562B | 0.00 |
Revvity (RVTY) | United States | $10.871B | 18.71 |
ICON (ICLR) | Ireland | $10.610B | 9.86 |
Viatris (VTRS) | United States | $10.094B | 3.47 |
Doximity (DOCS) | United States | $9.727B | 45.30 |
Avantor (AVTR) | United States | $8.961B | 13.02 |
HealthEquity (HQY) | United States | $8.748B | 43.04 |
Medpace Holdings (MEDP) | United States | $8.582B | 22.79 |
Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
Charles River Laboratories (CRL) | United States | $6.810B | 13.35 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
Bausch + Lomb (BLCO) | Canada | $4.171B | 24.58 |
BrightSpring Health Services (BTSG) | United States | $4.074B | 37.71 |
Sotera Health (SHC) | United States | $3.528B | 20.05 |
Surgery Partners (SGRY) | United States | $2.954B | 38.42 |
Alignment Healthcare (ALHC) | United States | $2.920B | 0.00 |
Concentras Parent (CON) | United States | $2.761B | 15.96 |
Organon (OGN) | United States | $2.376B | 2.52 |
Ardent Health Partners (ARDT) | United States | $2.127B | 9.07 |
GeneDx Holdings (WGS) | United States | $1.997B | 76.91 |
Premier (PINC) | United States | $1.896B | 14.39 |
Progyny (PGNY) | United States | $1.765B | 38.85 |
PACS (PACS) | United States | $1.558B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.368B | 27.36 |
Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
Pediatrix Medical (MD) | United States | $1.190B | 9.05 |
Establishment Labs Holdings (ESTA) | $1.067B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
CareDx (CDNA) | United States | $0.982B | 15.33 |
Agilon Health (AGL) | United States | $0.923B | 0.00 |
Nutex Health (NUTX) | United States | $0.911B | 13.77 |
AMN Healthcare Services Inc (AMN) | United States | $0.822B | 7.70 |
QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
Embecta (EMBC) | United States | $0.658B | 4.43 |
InnovAge Holding (INNV) | United States | $0.545B | 0.00 |
Enhabit (EHAB) | United States | $0.529B | 43.54 |
LifeMD (LFMD) | United States | $0.524B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.484B | 10.90 |
SBC Medicals (SBC) | United States | $0.477B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.400B | 0.00 |
Oncology Institute (TOI) | United States | $0.269B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.220B | 0.00 |
Beauty Health (SKIN) | United States | $0.213B | 0.00 |
KindlyMD (NAKA) | United States | $0.151B | 0.00 |
KindlyMD (KDLY) | United States | $0.150B | 0.00 |
DocGo (DCGO) | United States | $0.142B | 23.17 |
OncoCyte (OCX) | United States | $0.093B | 0.00 |
So-Young (SY) | China | $0.090B | 0.00 |
Sera Prognostics (SERA) | United States | $0.063B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
Biodesix (BDSX) | United States | $0.051B | 0.00 |
Pheton Holdings (PTHL) | China | $0.038B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.020B | 0.00 |
ModivCare (MODV) | United States | $0.013B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
INVO Fertility (IVF) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |